Membership Directory
Arietis Corporation
Category: Drug Development
Phone: +1 (617) 638-0370
Fax: +1 (617) 358-5001
Website: http://www.arietiscorp.com
Location: Boston, MA
Arietis is a Boston-based biotechnology company focused on the discovery and development of novel antimicrobial agents, including both sterilizing antifungals and a new class of antibacterial agents called “prodrug antibiotics”. Founded in 2006, the Arietis approach and technology are totally novel and will bridge the current vacuum in antimicrobial therapeutics. Arietis has forged productive alliances and partnerships within the biotechnology community that advance our capacity to develop effective drug products. We are committed to providing innovative solutions to the problem of persistent infections, thereby decreasing the burden on health systems worldwide.
Back to list
The company was created based on technology invented by its founder, Professor Kim Lewis, Director of the Antimicrobial Center at Northeastern University, for which the company has obtained exclusive, world-wide licenses. Arietis is led by Dr. Thomas A. Dahl, CEO, an experienced business executive and drug developer.
